- Home
- INO vs GGZ Comparison
INO vs GGZ Comparison
Compare INO & GGZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INO | GGZ |
|---|---|---|
| Founded | 1979 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.1M | 125.0M |
| IPO Year | 1998 | N/A |
Fundamental Metrics
Financial Performance| Metric | INO | GGZ |
|---|---|---|
| Price | $1.58 | $16.20 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 12.8K |
| Earning Date | 03-17-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 5.39% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.75 |
| Revenue | ★ $182,337.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $23,060.18 | N/A |
| P/E Ratio | ★ N/A | $6.79 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.30 | $9.43 |
| 52 Week High | $2.98 | $12.50 |
Technical Indicators
Market Signals| Indicator | INO | GGZ |
|---|---|---|
| Relative Strength Index (RSI) | 43.10 | 70.75 |
| Support Level | $1.54 | $16.06 |
| Resistance Level | $1.78 | $16.40 |
| Average True Range (ATR) | 0.11 | 0.20 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 32.79 | 97.85 |
Price Performance
Historical ComparisonAbout INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
About GGZ Gabelli Global Small and Mid Cap Value Trust (The) of Beneficial Interest
The Gabelli Global Small and Mid Cap Value Trust is a diversified closed-ended management investment company whose investment objective is long-term capital growth. It invests in equity securities such as common stock and preferred stock of companies.